San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Trovagene Settles Lawsuit With Former Execs

Local medical test maker Trovagene Inc. has resolved a year-long legal dispute between the company and its former chief executive officer and former chief financial officer.

By Brittany Meiling July 31, 2017 3:11 p.m. share »

Clinical Trial Results Prove Positive For Samumed

Samumed, the San Diego biotech with a $12 billion valuation, has wrapped up a mid-stage clinical trial that has the company optimistic about its future.

By Brittany Meiling July 31, 2017 1:37 p.m. share »

Senomyx Reports Q2 Results

Public biotech and flavor enhancer company Senomyx Inc. reported down revenue for the second quarter of this year.

By Brittany Meiling July 28, 2017 11:22 a.m. share »

NuVasive Restructures C-Suite, Announces Q2 Revenues

Local medical device maker NuVasive Inc. on Thursday announced a restructuring of its executive suite, including the pending departures of its president/chief operating officer and chief finance officer. The company, known for disrupting the spinal surgery market, said the changes are intended to drive growth and profitability as it strives to hit $1 billion in revenues in 2017.

By Tarcy Connors July 27, 2017 2:51 p.m. share »
Tease photo

Ballentine Tapped to Lead CSU Institute for Palliative Care

Jennifer Moore Ballentine has been named the new executive director of the CSU Institute for Palliative Care.

By Sarah de Crescenzo July 27, 2017 1:20 p.m. share »

Struggling Drugmaker Raises $43 Million in Stock Offering

Local drugmaker Regulus Therapeutics Inc. has managed to raise $43 million in a public stock offering — cash the struggling company needs to continue its research.

By Brittany Meiling July 26, 2017 4:26 p.m. share »

FDA Grants Special Status to Biotech's Drug

Regulators with the U.S. Food and Drug Administration have handed local biotech Samumed LLC a special classification for one of its drug programs, granting the company a number of perks.

By Brittany Meiling July 25, 2017 5:38 p.m. share »
Tease photo

Diagnostics Co. Must Wait for the Results

One of San Diego’s bigger (yet little-known) public companies, Quidel Corp., just inked a deal that could double its annual revenue. But the deal’s closure is dependent on outside forces that may or may not go Quidel’s way.

By Brittany Meiling July 25, 2017 8:04 a.m. share »
Tease photo

New Drug, New Attitude, New Day at Pharma Co.

Its diet pill was a commercial flop that almost sent Arena Pharmaceuticals Inc. to the grave. But now, following a major makeover, the company’s new experimental medicines could bring renewed life to the San Diego biotech.

By br July 25, 2017 7:59 a.m. share »

Effector Therapeutics Raises $38.6 Million From Pfizer Venture

Local biotech Effector Therapeutics Inc. has raised $38.6 million in a Series C venture capital round led by big pharma investor Pfizer Venture Investments.

By Brittany Meiling July 24, 2017 3:57 p.m. share »

New Drug, New Attitude: New Day at Pharma Company

Its diet pill was a commercial flop that almost sent Arena Pharmaceuticals Inc. to the grave. But now, following a major makeover, the company’s new experimental medicines could bring renewed life to the San Diego biotech.

By Brittany Meiling July 21, 2017 2:38 p.m. share »

Neurocrine Names Julie Cooke as Chief People Officer

Local drugmaker Neurocrine Biosciences Inc. has hired Julie Cooke to serve as part of the company’s management committee with the title chief people officer.

By Brittany Meiling July 21, 2017 1:16 p.m. share »

Windward Life Care Is Acquiring Lifeline Care at Home

A local aging services company called Windward Life Care has acquired San Diego’s longstanding senior care organization, Lifeline Care at Home.

By Brittany Meiling July 21, 2017 11:32 a.m. share »

Imprimis Pharmaceuticals Borrows $16 Million

San Diego drugmaker Imprimis Pharmaceuticals Inc. has entered into a $16 million loan agreement with SWK Funding and its partners, the company announced Thursday.

By Brittany Meiling July 20, 2017 4:34 p.m. share »

Aspyrian Therapeutics Raises $15.1 Million

San Diego’s Aspyrian Therapeutics Inc. has raised $15.1 million in a Series B-1 financing round. The company expects the round will increase to $19 million in the next few weeks.

By Brittany Meiling July 20, 2017 2:40 p.m. share »